Convalescent plasma for COVID-19: enthusiasm has outweighed the evidence

Hospitalised patients with moderate COVID-19 gain no benefit from convalescent plasma on progression to severe disease or mortality, new research shows. The findings of an open-label RCT published in the BMJ further weaken any case for any effect of serum containing viral antibodies collected from people recovering from COVID-19 disease, coming on top of previously ...

Already a member?

Login to keep reading.

© 2021 the limbic